Research study Program year 2025 Source: CMS Open Payments

Phase 1c Selnoflast Proof of Concept

Research payments

$2,229,024

397 payments

Through program year 2025, $2,229,024 in research payments was reported against Phase 1c Selnoflast Proof of Concept, across 397 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$67,079	30
2024	Research	$1,489,084	217
2023	Research	$672,861	150

Breakdown

Who paid Research payments · program years 2023–2025

Genentech, Inc. $2,229,024 397 payments

Who received the money Research payments · program years 2023–2025

Massachusetts General Hospital Teaching hospital · MA $1,146,662 34 payments
Clinical Site Partners D B A C Organisation paid for research $196,939 85 payments
Quintiles Biosciences INC Organisation paid for research $146,629 1 payment
Board Of Trustees Of The Leland Stanford Junior University Organisation paid for research $98,542 26 payments
Innovative Research of West Florida, Inc. Organisation paid for research $85,415 73 payments
Chicago Medical Research LLC Organisation paid for research $81,150 31 payments
Velocity Clinical Research INC Organisation paid for research $78,029 14 payments
Metropolitan Cardiovascular Organisation paid for research $71,997 26 payments
Biomedical Research Alliance Of New York Organisation paid for research $58,616 16 payments
Blue Coast Research Center, LLC Organisation paid for research $54,768 21 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.